Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€6.15

€6.15

-3.910%
-0.25
-3.910%
-
 
09.04.25 / Stuttgart Stock Exchange WKN: A2P7Z2 / Name: Accolade Inc. / Stock / ? / We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Your prediction

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Accolade Inc. is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Accolade Inc.

sharewise wants to provide you with the best news and tools for Accolade Inc., so we directly link to the best financial data sources.

News

Accolade Inc Stock: $621M Transcarent Buyout Sends Shares Soaring
Accolade Inc Stock: $621M Transcarent Buyout Sends Shares Soaring

Accolade Inc, a health technology company with a $572 million market capitalization, has announced its pending acquisition by Transcarent in a cash deal valued at $621 million. The transaction

Accolade Inc Stock: Transcarent Acquisition Values Company at $621M
Accolade Inc Stock: Transcarent Acquisition Values Company at $621M

Accolade Inc is set to undergo a significant transformation following Transcarent's announcement to acquire the healthcare technology company for $621 million. The deal, which values Accolade shares